| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $164.4M | — | +5.5% |
| Cost of Revenue | $60.4M | — | -3.8% |
| R&D Expense | $25.2M | — | +12.9% |
| SG&A Expense | $25.0M | — | +4.4% |
| Operating Income | $7.7M | — | +665.9% |
| Interest Expense | $7.0M | — | -16.8% |
| Pre-tax Income | $3.7M | — | +135.6% |
| Income Tax | -$681K | — | +20.2% |
| Net Income | $4.4M | — | +145.8% |
| EPS (Basic) | $0.03 | — | +142.9% |
| EPS (Diluted) | $0.03 | — | +142.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $184.6M | -66.6% | -57.0% |
| Accounts Receivable | $1.43B | +9.9% | +35.8% |
| Current Assets | $1.65B | -12.4% | +8.7% |
| Total Assets | $2.95B | -6.9% | +10.2% |
| Current Liabilities | $1.62B | -12.0% | +5.4% |
| Long-term Debt | $350.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$120.8M | — | -4815.6% |
| Capital Expenditures | $9.4M | — | -34.6% |
| Investing Cash Flow | -$13.1M | — | +23.7% |
| Financing Cash Flow | -$235.1M | — | -495.9% |
| Free Cash Flow | -$130.2M | — | -1001.6% |
| -37.0% |
| Total Liabilities | $2.03B | -9.5% | +5.0% |
| Stockholders' Equity | $917.9M | -0.5% | +23.7% |